Supportive of our hypothesis is recently published data by Chen and colleagues showed in a NSCLC model system that combined SHP2 and PD-L1 inhibition, with accompanying radiation, can overcome resistance to PD-1 inhibitors [11]. Here, CD274 is linked to non-small cell lung carcinoma.